ModelEdge

Processa Pharmaceuticals Inc.
PCSA
Filing Type8-K
Filing Date7/28/2026
Updated7/29/26, 6:50 AM

Filing

8-K
Earnings Release

Exhibits

8-KMaterial Contracts, End of Material Contract, Completing Asset Acquisition or Sale, Unregistered Sales of Equity Securities, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Reg. FD
EX-2.1EX-2.1
EX-3.1EX-3.1
EX-10.1EX-10.1
EX-10.2EX-10.2
EX-99.1Material Contracts, End of Material Contract, Completing Asset Acquisition or Sale, Unregistered Sales of Equity Securities, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Reg. FD
EX-99.2Material Contracts, End of Material Contract, Completing Asset Acquisition or Sale, Unregistered Sales of Equity Securities, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Reg. FD
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic